Guidelines on the Management of Patients with PAD

In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

Faculty:
Marc Bonaca, MD, MPH
Professor of Medicine
Director of Vascular Research
University of Colorado School Medicine
Aurora, CO

Dr. Bonaca has reported the following relevant financial relationships or relationship with ineligible companies of any amount during the past 24 months:
Research grant/Consulting fees: Abbott Laboratories, Agios Pharmaceuticals, Inc., Alexion Pharma, Alnylam Pharmaceuticals, Inc., Amgen Inc., Angionetics, Inc., Anthos Therapeutics, ARCA Biopharma, Inc., Array BioPharma, Inc., AstraZeneca and Affiliates, Atentiv LLC, Audentes Therapeutics, Inc., Bayer and Affiliates, Beth Israel Deaconess Medical Center, Better Therapeutics, Inc., Boston Clinical Research Institute, Bristol-Meyers Squibb Company, Cambrian Biopharma, Inc., Cardiol Therapeutics Inc., CellResearch Corp., Cleerly Inc., Cook Regentec LLC, CSL Behring LLC, Eidos Therapeutics, Inc., EP Trading Co. Ltd., EPG Communication Holdings Ltd., Epizon Pharma, Inc., Esperion Therapeutics, Inc., Everly Well, Inc., Exicon Consulting Pvt. Ltd., Faraday Pharmaceuticals, Inc., Foresee Pharmaceuticals Co. Ltd., Fortress Biotech, Inc., HDL Therapeutics Inc., HeartFlow Inc., Hummingbird Bioscience, Insmed Inc., Ionis Pharmaceuticals, IQVIA Inc., Janssen and Affiliates, Kowa Research Institute, Inc., Kyushu University, Lexicon Pharmaceuticals, Inc., Medimmune Ltd., Medpace, Merck & Affiliates, Nectero Medical Inc., Novartis Pharmaceuticals Corp., Novo Nordisk, Inc., Osiris Therapeutics Inc., Pfizer Inc., PhaseBio Pharmaceuticals, Inc., PPD Development, LP, Prairie Education and Research Cooperative, Prothena Biosciences Limited, Regeneron Pharmaceuticals, Inc., Regio Biosciences, Inc., Saint Luke’s Hospital of Kansas City, Sanifit Therapeutics S.A., Sanofi-Aventis Groupe, Silence Therapeutics PLC, Silence, Smith & Nephew plc, Stanford Center for Clinical Research, Stealth BioTherapeutics Inc., State of Colorado CCPD Grant, The Brigham & Women's Hospital, Inc., The Feinstein Institutes for Medical Research, Thrombosis Research Institute, University of Colorado, University of Pittsburgh, VarmX, Virta Health Corporation, Worldwide Clinical Trials Inc., WraSer, LLC, and Yale Cardiovascular Research Group, and AHA SFRN under award numbers 18SFRN3390085 (BWH-DH SFRN Center) and 18SFRN33960262 (BWH-DH Clinical Project). 

Alik Farber, MD, MBA, FACS, DFSVS
Interim Chair, Department of Surgery
Professor of Surgery and Radiology
Boston University Chobanian & Avedisian School of Medicine
Interim Chief, Department of Surgery
Associate Chief Medical Officer for Surgical Services
Chief, Division of Vascular & Endovascular Surgery
Boston Medical Center
Boston, MA

Dr. Farber has reported the following relevant financial relationships or relationship with ineligible companies of any amount during the past 24 months:
Consulting fees: BiogenCell, LeMaitre, and Sanifit.

Naomi Hamburg, MD, MS
Joseph Vita Professor of Cardiovascular Medicine
Boston University Chobanian and Avedisian School of Medicine
Boston, MA

Dr. Hamburg Dr. Farber has reported the following relevant financial relationships or relationship with ineligible companies of any amount during the past 24 months:
Consulting fees: Boston Scientific, and Fukuda.

Connie N. Hess, MD, MHS
Associate Professor of Medicine
Division of Cardiology
University of Colorado School of Medicine
Aurora, CO 

Dr. Hess has reported the following relevant financial relationships or relationship with ineligible companies of any amount during the past 24 months:
Research fees: Amgen, Bayer, and Janssen

Schuyler Jones, MD
Associate Professor of Medicine
Duke University Health System
Durham, NC

Dr. Joneshas reported the following relevant financial relationships or relationship with ineligible companies of any amount during the past 24 months:
Research fees: Bayer, Bristol Myers Squibb, Merck, and Novartis.

Manesh R. Patel, MD
Richard S. Stack Distinguished Professor
Chief, Division of Cardiology
Co-Director Duke Heart Center
Duke Clinical Research Institute
Duke University
Durham, NC

Dr. Patel has reported the following relevant financial relationships or relationship with ineligible companies of any amount during the past 24 months:
Research Fees: AstraZeneca, Bayer, Janssen, Mytonomy, and Procyrion
Consulting fees: Bayer, Janssen, and Novartis

Reviewers/Content Planners/Authors:

• Prerna Poojary has nothing to disclose.
• Brian P. McDonough, MD, FAAFP has nothing to disclose.